Clinical Trial: Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
Clinical Trial: Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgerySponsor and Collaborators
National Cancer Institute (NCI)
Principal Investigator
Roxana Dronca, Mayo Clinic
ClinicalTrials.gov Identifier
NCT01328535
